Pulmonx Operating Income 2019-2023 | LUNG
Pulmonx Annual Operating Income (Millions of US $) |
|
---|---|
2023 | $-62 |
2022 | $-59 |
2021 | $-47 |
2020 | $-32 |
2019 | $-18 |
2018 | $-15 |
Pulmonx Quarterly Operating Income (Millions of US $) |
|
---|---|
2023-12-31 | $-14 |
2023-09-30 | $-15 |
2023-06-30 | $-16 |
2023-03-31 | $-16 |
2022-12-31 | $-15 |
2022-09-30 | $-14 |
2022-06-30 | $-14 |
2022-03-31 | $-16 |
2021-12-31 | $-12 |
2021-09-30 | $-10 |
2021-06-30 | $-13 |
2021-03-31 | $-12 |
2020-12-31 | $-9 |
2020-09-30 | $-5 |
2020-06-30 | $-12 |
2020-03-31 | $-6 |
2019-12-31 | |
2019-09-30 | $-4 |
2018-12-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.298B | $0.069B |
Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
GE HealthCare Technologies (GEHC) | United States | $35.723B | 19.61 |
Inspire Medical Systems (INSP) | United States | $7.393B | 0.00 |
IRhythm Technologies (IRTC) | United States | $3.477B | 0.00 |
Axonics (AXNX) | United States | $3.412B | 0.00 |
10x Genomics (TXG) | United States | $3.208B | 0.00 |
Enovis (ENOV) | United States | $3.038B | 23.08 |
Azenta (AZTA) | United States | $2.905B | 236.82 |
Olink Holding AB (publ) (OLK) | Sweden | $2.820B | 0.00 |
Hims & Hers Health (HIMS) | United States | $2.680B | 0.00 |
Privia Health (PRVA) | United States | $2.139B | 94.89 |
Schrodinger (SDGR) | United States | $1.827B | 0.00 |
Omnicell (OMCL) | United States | $1.248B | 30.53 |
Phreesia (PHR) | United States | $1.185B | 0.00 |
Definitive Healthcare (DH) | United States | $0.821B | 0.00 |
Standard BioTools (LAB) | United States | $0.737B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.680B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.619B | 0.00 |
Talkspace (TALK) | United States | $0.536B | 0.00 |
Health Catalyst (HCAT) | United States | $0.373B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.329B | 0.00 |
Clover Health Investments (CLOV) | United States | $0.318B | 0.00 |
P3 Health Partners (PIII) | United States | $0.183B | 0.00 |
Butterfly Network (BFLY) | United States | $0.164B | 0.00 |
American Well (AMWL) | United States | $0.154B | 0.00 |
Outset Medical (OM) | United States | $0.147B | 0.00 |
MSP Recovery (LIFW) | United States | $0.129B | 0.00 |
Augmedix (AUGX) | United States | $0.124B | 0.00 |
TruBridge (TBRG) | United States | $0.118B | 5.04 |
111 (YI) | China | $0.088B | 0.00 |
Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.068B | 0.00 |
HeartBeam (BEAT) | United States | $0.057B | 0.00 |
Zepp Health (ZEPP) | China | $0.052B | 0.00 |
Movano (MOVE) | United States | $0.048B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.046B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.033B | 0.00 |
Akili (AKLI) | United States | $0.031B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.025B | 0.00 |
Cue Health (HLTH) | United States | $0.021B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.019B | 0.00 |
CareCloud (CCLD) | United States | $0.018B | 0.00 |
ETAO (ETAO) | United States | $0.016B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.014B | 0.00 |
Biotricity (BTCY) | United States | $0.013B | 0.00 |
Transgenomic (PRPO) | United States | $0.008B | 0.00 |
Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
HeartSciences (HSCS) | United States | $0.006B | 0.00 |
Syra Health (SYRA) | United States | $0.006B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
Zhongchao (ZCMD) | China | $0.003B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
Centogene (CNTG) | Germany | $0.000B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |